P Øgreid

443 total citations
21 papers, 346 citations indexed

About

P Øgreid is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, P Øgreid has authored 21 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in P Øgreid's work include Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Urinary and Genital Oncology Studies (5 papers). P Øgreid is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Urinary and Genital Oncology Studies (5 papers). P Øgreid collaborates with scholars based in Norway, Netherlands and India. P Øgreid's co-authors include Kjell H. Kjellevold, Oddvar Mestad, Jan P. A. Baak, Arnold‐Jan Kruse, Truls E. Bjerklund Johansen, Bernt Kvarstein, Sigurd Ous, Arne Heilo, B Klevmark and SD Fosså and has published in prestigious journals such as Cancer, The Journal of Urology and British Journal of Cancer.

In The Last Decade

P Øgreid

20 papers receiving 328 citations

Peers

Countries citing papers authored by P Øgreid

Since Specialization

Citations

This map shows the geographic impact of P Øgreid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Øgreid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Øgreid more than expected).

Fields of papers citing papers by P Øgreid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Øgreid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Øgreid. The network helps show where P Øgreid may publish in the future.

Co-authorship network of co-authors of P Øgreid

This figure shows the co-authorship network connecting the top 25 collaborators of P Øgreid. A scholar is included among the top collaborators of P Øgreid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Øgreid. P Øgreid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Intravenous cyclophosphamide in patients with chronic systemic inflammatory diseases: morbidity and mortality	Scandinavian Journal of Rheumatology	Lasse G. Gøransson, P Øgreid et al.	6
2	Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer	Acta Oncologica	Ása Karlsdóttir, L.P. Muren et al.	7
3	[Scrotal pain and Henoch-Schönlein purpura].	PubMed	Kjetil Søreide, Christoph Ansorge et al.	3
4	DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality	Urology	Jan P. A. Baak, Bianca van Diermen et al.	16
5	Reproducibility and Prognostic Variability of Grade and Lamina Propria Invasion in Stages Ta, T1 Urothelial Carcinoma of the Bladder	The Journal of Urology	Jan P. A. Baak, Arnold‐Jan Kruse et al.	118
6	[Normal tissue radiation toxicity in radiotherapy of localized prostatic cancer].	PubMed	P Øgreid et al.	1
7	Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study	British Journal of Cancer	S.D. Fosså, Sigmund Vaage et al.	21
8	How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?	British Journal of Cancer	SD Fosså, Nina Aass et al.	22
9	Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer	British Journal of Cancer	SD Fosså, Håkon Wæhre et al.	17
10	A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer	Cancer	Sigurd Ous, B Klevmark et al.	50
11	[Synchronous bilateral testicular cancer with different histologies].	PubMed	P Øgreid et al.	1
12	Testicular Histology after Treatment with LH‐RH Analogue for Carcinoma of the Prostate	British Journal of Urology	Truls E. Bjerklund Johansen, P Øgreid et al.	12
13	Digital Rectal Examination to Screen for Prostatic Cancer(1)	European Urology	Edward Stenehjem, P Øgreid et al.	14
14	Noninvasive evaluation of the enlarged prostate preliminary results.	PubMed	P Øgreid, Oddvar Mestad et al.	0
15	Venous Pressure Gradients in Patients with Chronic Venous Disease	Phlebology The Journal of Venous Disease	E. Stranden, P Øgreid et al.	9
16	High-Dose Medroxyprogesterone Acetate versus Prednisolone inHormone-Resistant Prostatic Cancer	European Urology	Sophie D. Fosså, Steinar Karlsen et al.	15
17	[Jejunogastric invagination as a complication after stomach surgery].	PubMed	P Øgreid, I Liavåg et al.	1
18	Cyst of Seminal Vesicle Associated with Ipsilateral Renal Agenesis	Scandinavian Journal of Urology and Nephrology	P Øgreid et al.	18
19	Traumatic Haematuria in Supernumerary Hydronephrotic Kidney	Scandinavian Journal of Urology and Nephrology	P Øgreid et al.	3
20	Development of Carcinoma Urethrae after Operation for Stricture of the Urethra: Case Report	Scandinavian Journal of Urology and Nephrology	P Øgreid	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact